Literature DB >> 33584489

A Challenging Diagnosis of Atypical Glut1-DS: A Case Report and Literature Review.

Miaomiao Yu1, Jing Miao1, Yudan Lv1, Xue Wang2, Wuqiong Zhang1, Na Shao3, Hongmei Meng1.   

Abstract

Glucose transporter type 1 deficiency syndrome (Glut1-DS) is a rare neurometabolic disorder caused by mutations of the SLC2A1 gene. Paroxysmal exercise-induced dyskinesia is regarded as a representative symptom of Glut1-DS. Paroxysmal non-kinesigenic dyskinesia is usually caused by aberrations of the MR1 and KCNMA1 genes, but it also appears in Glut1-DS. We herein document a patient with Glut1-DS who suffered first from paroxysmal exercise-induced dyskinesia and subsequently paroxysmal non-kinesigenic dyskinesia and experienced a recent worsening of symptoms accompanied with a low fever. The lumbar puncture result showed a decreased glucose concentration and increased white blood cell (WBC) count in cerebrospinal fluid (CSF). The exacerbated symptoms were initially suspected to be caused by intracranial infection due to a mild fever of <38.0°C, decreased CSF glucose, and increased CSF WBC count. However, the second lumbar puncture result indicated a decreased glucose concentration and normal WBC count in CSF with no anti-infective agents, and the patient's symptoms were not relieved apparently. The continuous low glucose concentration attracted our attention, and gene analysis was performed. According to the gene analysis result, the patient was diagnosed with Glut1-DS finally. This case indicates that the complex paroxysmal dyskinesia in Glut1-DS may be confusing and pose challenges for accurate diagnosis. Except intracranial infection, Glut1-DS should be considered as a differential diagnosis upon detection of a low CSF glucose concentration and dyskinesia. The case presented here may encourage clinicians to be mindful of this atypical manifestation of Glut1-DS in order to avoid misdiagnosis.
Copyright © 2021 Yu, Miao, Lv, Wang, Zhang, Shao and Meng.

Entities:  

Keywords:  GLUT1-DS; SLC2A1; intracranial infection; ketogenic diet; paroxysmal exercise-induced dyskinesia; paroxysmal non-kinesigenic dyskinesia

Year:  2021        PMID: 33584489      PMCID: PMC7876440          DOI: 10.3389/fneur.2020.549331

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  17 in total

1.  Keeping Glucose Transporter Type 1 Deficiency Syndrome in Mind: A Late Diagnosis and Unusual Neuroimage Findings.

Authors:  Victoria Ros-Castelló; Rafael Toledano; Juan S Martínez-San-Millán; Araceli Alonso-Canovas
Journal:  Mov Disord Clin Pract       Date:  2019-03-28

2.  Characteristic proton magnetic resonance spectroscopy in glucose transporter type 1 deficiency syndrome.

Authors:  Manami Akasaka; Atsushi Kamei; Nami Araya; Kotaro Oyama; Makoto Sasaki
Journal:  Pediatr Int       Date:  2018-10-15       Impact factor: 1.524

Review 3.  Pathogenic mutations causing glucose transport defects in GLUT1 transporter: The role of intermolecular forces in protein structure-function.

Authors:  Mobeen Raja; Rolf K H Kinne
Journal:  Biophys Chem       Date:  2015-03-25       Impact factor: 2.352

4.  SLC2A1 mutations are a rare cause of pediatric-onset hereditary spastic paraplegia.

Authors:  Francesco Nicita; Tommaso Schirinzi; Fabrizia Stregapede; Gessica Vasco; Enrico Bertini; Lorena Travaglini
Journal:  Eur J Paediatr Neurol       Date:  2018-12-18       Impact factor: 3.140

5.  Familial paroxysmal exercise-induced dyskinesia and benign epilepsy: a clinical and neurophysiological study of an uncommon disorder.

Authors:  L Margari; T Perniola; G Illiceto; E Ferrannini; M G De Iaco; A Presicci; R Santostasi; P Ventura
Journal:  Neurol Sci       Date:  2000-06       Impact factor: 3.307

6.  From splitting GLUT1 deficiency syndromes to overlapping phenotypes.

Authors:  Marie Hully; Sandrine Vuillaumier-Barrot; Christiane Le Bizec; Nathalie Boddaert; Anna Kaminska; Karine Lascelles; Pascale de Lonlay; Claude Cances; Vincent des Portes; Agathe Roubertie; Diane Doummar; Anne LeBihannic; Bertrand Degos; Anne de Saint Martin; Elisabeth Flori; Jean Michel Pedespan; Alice Goldenberg; Catherine Vanhulle; Soumeya Bekri; Anne Roubergue; Bénédicte Heron; Marie-Anne Cournelle; Alice Kuster; Alexis Chenouard; Marie-Noelle Loiseau; Vassili Valayannopoulos; Nicole Chemaly; Cyril Gitiaux; Nathalie Seta; Nadia Bahi-Buisson
Journal:  Eur J Med Genet       Date:  2015-07-17       Impact factor: 2.708

Review 7.  Child neurology: differential diagnosis of a low CSF glucose in children and young adults.

Authors:  Wilhelmina G Leen; Cornelis J de Wit; Ron A Wevers; Baziel G van Engelen; Erik-Jan Kamsteeg; Joerg Klepper; Marcel M Verbeek; Michèl A Willemsen
Journal:  Neurology       Date:  2013-12-10       Impact factor: 9.910

8.  GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.

Authors:  Yvonne G Weber; Alexander Storch; Thomas V Wuttke; Knut Brockmann; Judith Kempfle; Snezana Maljevic; Lucia Margari; Christoph Kamm; Susanne A Schneider; Stephan M Huber; Arnulf Pekrun; Robert Roebling; Guiscard Seebohm; Saisudha Koka; Camelia Lang; Eduard Kraft; Dragica Blazevic; Alberto Salvo-Vargas; Michael Fauler; Felix M Mottaghy; Alexander Münchau; Mark J Edwards; Anna Presicci; Francesco Margari; Thomas Gasser; Florian Lang; Kailash P Bhatia; Frank Lehmann-Horn; Holger Lerche
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  GLUT1 deficiency syndrome: an update.

Authors:  D Gras; E Roze; S Caillet; A Méneret; D Doummar; T Billette de Villemeur; M Vidailhet; F Mochel
Journal:  Rev Neurol (Paris)       Date:  2013-11-20       Impact factor: 2.607

10.  Paroxysmal eye-head movements in Glut1 deficiency syndrome.

Authors:  Toni S Pearson; Roser Pons; Kristin Engelstad; Steven A Kane; Michael E Goldberg; Darryl C De Vivo
Journal:  Neurology       Date:  2017-03-24       Impact factor: 9.910

View more
  1 in total

1.  Analysis of Cerebrospinal Fluid Routine Biochemical Level, Pathogenic Bacteria Distribution, and Risk Factors in Patients with Secondary Intracranial Infection after Brain Tumor Surgery.

Authors:  Yang Zhang; Ying Zhou; Min Hou; Sunfu Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-16       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.